Alexandria Real Estate Equities and Continental Grain Company have backed the first close of the Syngenta-backed agricultural bioprocessing platform's latest round.
US-based bioprocessing technology developer GreenLight Biosciences received $50m from investors including food producer Continental Grain Company on Tuesday to close the first tranche of its latest funding round. Life sciences real estate investment trust Alexandria Real Estate Equities took part in the round, through its Alexandria Venture Investments unit. S2G Ventures, Baird Capital, Blue I/O…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.